Leukemia & Lymphoma, Volume 56, Issue 2 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 56, Issue 2 (2015)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Volume 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary on selected article in this issue

Article Commentary
Treating chronic lymphocytic leukemia with a combination of rituximab and alemtuzumab: a “successful couple,” but are they still relevant together?
Christian H. Geisler, Tamar Tadmor & Aaron Polliack
Pages: 275-276
Published online: 20 Aug 2014
CitationforTreating chronic lymphocytic leukemia with a combination of rituximab and alemtuzumab: a “successful couple,” but are they still relevant together? | Full Text | References | PDF (90.8 KB) | Supplemental
  • 476 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Commentaries on selected articles in this issue

Article Commentary
New clues to the prognostic challenge of Hodgkin lymphoma
Martin Hutchings & Peter Kamper
Pages: 277-278
Published online: 19 Nov 2014
CitationforNew clues to the prognostic challenge of Hodgkin lymphoma | Full Text | References | PDF (84.5 KB) | Supplemental
  • 526 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Ruxolitinib and DNA methyltransferase-inhibitors: a foray into combination regimens in myelofibrosis
Naval Daver & Srdan Verstovsek
Pages: 279-280
Published online: 15 Jul 2014
CitationforRuxolitinib and DNA methyltransferase-inhibitors: a foray into combination regimens in myelofibrosis | Full Text | References | PDF (92.2 KB) | Supplemental
  • 964 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Long non-coding RNAs in primary myelofibrosis: the dark matter in hematopoietic progenitor cells?
Katrien Van Roosbroeck, Srdan Verstovsek & George A. Calin
Pages: 281-282
Published online: 05 Aug 2014
CitationforLong non-coding RNAs in primary myelofibrosis: the dark matter in hematopoietic progenitor cells? | Full Text | References | PDF (89.1 KB) | Supplemental
  • 719 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
New frontiers for brentuximab vedotin for lymphomas
Alison J. Moskowitz
Pages: 283-284
Published online: 19 Nov 2014
CitationforNew frontiers for brentuximab vedotin for lymphomas | Full Text | References | PDF (88.9 KB) | Supplemental
  • 1081 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Emerging therapies for refractory chronic lymphocytic leukemia
Nadine Kutsch, Michael Hallek & Barbara Eichhorst
Pages: 285-292
Published online: 27 Jun 2014
AbstractforEmerging therapies for refractory chronic lymphocytic leukemia | Full Text | References | PDF (395.5 KB) | Supplemental
  • 612 Views
  • 1 CrossRef citations
  • 0Altmetric
Review Article
Relapsed/refractory diffuse large B-cell lymphoma: review of the management of transplant-eligible patients
Joshua Lukenbill & Brian Hill
Pages: 293-300
Published online: 16 Jun 2014
AbstractforRelapsed/refractory diffuse large B-cell lymphoma: review of the management of transplant-eligible patients | Full Text | References | PDF (150 KB) | Supplemental
  • 1129 Views
  • 6 CrossRef citations
  • 0Altmetric
Review Article
Splenic marginal-zone lymphoma: ontogeny and genetics
Panagiotis Baliakas, Jonathan C. Strefford, Vasilis Bikos, Marina Parry, Kostas Stamatopoulos & David Oscier
Pages: 301-310
Published online: 19 Aug 2014
AbstractforSplenic marginal-zone lymphoma: ontogeny and genetics | Full Text | References | PDF (1.5 MB) | Supplemental
  • 757 Views
  • 9 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication
Deborah A. Bowen, Kari G. Rabe, Susan M. Schwager, Susan L. Slager, Timothy G. Call, David S. Viswanatha & Clive S. Zent
Pages: 311-314
Published online: 25 Jun 2014
AbstractforInfectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication | Full Text | References | PDF (119 KB) | Supplemental
  • 305 Views
  • 12 CrossRef citations
  • 0Altmetric
Phase II study of alemtuzumab–rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes
Olga Frankfurt, Shuo Ma, Leo Gordon, Jane N. Winter, Jeanne M. Horowitz, Alfred Rademaker, Bing Bing Weitner, LoAnn C. Peterson, Jessica K. Altman, Martin S. Tallman, Adam Petrich & Steven T. Rosen
Pages: 315-323
Published online: 17 Jun 2014
AbstractforPhase II study of alemtuzumab–rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes | Full Text | References | PDF (311.5 KB) | Supplemental
  • 416 Views
  • 15 CrossRef citations
  • 0Altmetric
Assessment of clonality in T-cell large granular lymphocytic leukemia: flow cytometric T cell receptor Vβ repertoire and T cell receptor gene rearrangement
Zhi-Yuan Qiu, Wen-Yi Shen, Lei Fan, Li Wang, Hui Yu, Chun Qiao, Yu-Jie Wu, Rui-Nan Lu, Jun Qian, Guang-Sheng He, Wei Xu & Jian-Yong Li
Pages: 324-331
Published online: 17 Jul 2014
AbstractforAssessment of clonality in T-cell large granular lymphocytic leukemia: flow cytometric T cell receptor Vβ repertoire and T cell receptor gene rearrangement | Full Text | References | PDF (671 KB) | Supplemental
  • 548 Views
  • 6 CrossRef citations
  • 0Altmetric
CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment
Mohamed Touati, Manuela Delage-Corre, Jacques Monteil, Julie Abraham, Stéphane Moreau, Liliane Remenieras, Marie-Pierre Gourin, Nataliya Dmytruk, Agnès Olivrie, Pascal Turlure, Stéphane Girault, François Labrousse, Pierre-Marie Preux, Arnaud Jaccard & Dominique Bordessoule
Pages: 332-341
Published online: 27 Jun 2014
AbstractforCD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment | Full Text | References | PDF (896.8 KB) | Supplemental
  • 297 Views
  • 26 CrossRef citations
  • 0Altmetric
Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab
Rebecca L. Elstrom, Jia Ruan, Paul J. Christos, Peter Martin, Daniel Lebovic, Joseph Osborne, Stanley Goldsmith, June Greenberg, Richard R. Furman, Anca Avram, Ryan Putman, Erica Chapman, Madhu Mazumdar, Kent Griffith, Morton Coleman, John P. Leonard & Mark S. Kaminski
Pages: 342-346
Published online: 17 Jun 2014
AbstractforPhase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab | Full Text | References | PDF (398.7 KB) | Supplemental
  • 271 Views
  • 9 CrossRef citations
  • 0Altmetric
Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine
Philipp Zimmer, Andreas Mierau, Wilhelm Bloch, Heiko K. Strüder, Thorben Hülsdünker, Alexander Schenk, Leonie Fiebig, Freek T. Baumann, Moritz Hahn, Nina Reinart, Michael Hallek & Thomas Elter
Pages: 347-352
Published online: 05 Jun 2014
AbstractforPost-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine | Full Text | References | PDF (269.2 KB) | Supplemental
  • 1591 Views
  • 51 CrossRef citations
  • 0Altmetric
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics
Thomas Melchardt, Lukas Weiss, Clemens Hufnagl, Daniel Neureiter, Ralf Kemmerling, Patrick Morre, Ann Boekstegers, Georg Hopfinger, Jutta Auberger, Susanne Steinkirchner, Lisa Pleyer, Richard Greil & Alexander Egle
Pages: 353-360
Published online: 25 Jun 2014
AbstractforTreatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics | Full Text | References | PDF (422.6 KB) | Supplemental
  • 235 Views
  • 3 CrossRef citations
  • 0Altmetric
Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide
Mary R. Welch, Craig S. Sauter, Matthew J. Matasar, Geraldine Faivre, Susan A. Weaver, Craig H. Moskowitz & Antonio M. Omuro
Pages: 361-367
Published online: 27 Jun 2014
AbstractforAutologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide | Full Text | References | PDF (601.2 KB) | Supplemental
  • 1297 Views
  • 43 CrossRef citations
  • 0Altmetric
Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma
Christian Straka, Hans Salwender, Brigitte Schnabel, Michael Sandherr, Hannes Wandt, Kai Hübel, Christof Scheid, Bernd Metzner, Marcus Hentrich, Daniel Franke, Gloria Weidenegger, Mathias Freund, Orhan Sezer, Hermann Einsele, Axel Hinke & Bertold Emmerich
Pages: 368-376
Published online: 27 May 2014
AbstractforGranulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma | Full Text | References | PDF (1.3 MB) | Supplemental
  • 204 Views
  • 0 CrossRef citations
  • 0Altmetric
Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma
Ewa Bednaruk-Młyński, Joanna Pieńkowska, Adam Skórzak, Bogdan Małkowski, Waldemar Kulikowski, Edyta Subocz, Justyna Dzietczenia, Marta Zalewska, Krzysztof Leśniewski-Kmak, Renata Zaucha, Tomasz Wróbel & Jan M. Zaucha
Pages: 377-382
Published online: 27 Jun 2014
AbstractforComparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma | Full Text | References | PDF (165.7 KB) | Supplemental
  • 297 Views
  • 23 CrossRef citations
  • 0Altmetric
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma
Loretta J. Nastoupil, Pareen J. Shenoy, Alex Ambinder, Jean L. Koff, Ajay K. Nooka, Edmund K. Waller, Amelia Langston, Miray Seward, Jonathan L. Kaufman, Leon Bernal-Mizrachi, Nassoma King, Mary Jo Lechowicz, Sagar Lonial, Rajni Sinha & Christopher R. Flowers
Pages: 383-389
Published online: 17 Jul 2014
AbstractforIntensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma | Full Text | References | PDF (879.1 KB) | Supplemental
  • 321 Views
  • 7 CrossRef citations
  • 0Altmetric
The effect of decitabine dose modification and myelosuppression on response and survival in patients with myelodysplastic syndromes
Elias Jabbour, Guillermo Garcia-Manero, A. Megan Cornelison, Jorge E. Cortes, Farhad Ravandi, Naval Daver, Tapan Kadia, Angela Teng & Hagop Kantarjian
Pages: 390-394
Published online: 17 Jul 2014
AbstractforThe effect of decitabine dose modification and myelosuppression on response and survival in patients with myelodysplastic syndromes | Full Text | References | PDF (254.1 KB) | Supplemental
  • 468 Views
  • 6 CrossRef citations
  • 0Altmetric
Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome
Gail J. Roboz, H. Jean Khoury, Elias Jabbour, Wilena Session, Ellen K. Ritchie, Harry Miao, Stefan Faderl, Wei Zheng, Eric J. Feldman, Martha Arellano, J. Gilmour Morrison & Farhad Ravandi
Pages: 395-400
Published online: 02 May 2014
AbstractforPhase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome | Full Text | References | PDF (178.7 KB) | Supplemental
  • 286 Views
  • 3 CrossRef citations
  • 0Altmetric
Jagged-1: a new promising factor associated with favorable prognosis in patients with acute myeloid leukemia
Magdalena Czemerska, Agnieszka Pluta, Anna Szmigielska-Kaplon, Ewa Wawrzyniak, Barbara Cebula-Obrzut, Aleksandra Medra, Piotr Smolewski, Tadeusz Robak & Agnieszka Wierzbowska
Pages: 401-406
Published online: 15 Jul 2014
AbstractforJagged-1: a new promising factor associated with favorable prognosis in patients with acute myeloid leukemia | Full Text | References | PDF (256.8 KB) | Supplemental
  • 218 Views
  • 8 CrossRef citations
  • 0Altmetric
Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone
Haowei (Linda) Sun, Eshetu G. Atenafu, Elizabeth Yeboah, Donna E. Reece, Suzanne Trudel, Vishal Kukreti, Esther Masih-Khan, Andrew Winter & Christine Chen
Pages: 407-414
Published online: 07 Jul 2014
AbstractforIntermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone | Full Text | References | PDF (324 KB) | Supplemental
  • 791 Views
  • 8 CrossRef citations
  • 0Altmetric
Bortezomib-based induction therapy followed by intravenous busulfan–melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma
Margarita Blanes, José D. González, Juan J. Lahuerta, Paz Ribas, Ignacio Lorenzo, Blanca Boluda, Miguel A. Sanz & Javier de la Rubia
Pages: 415-419
Published online: 17 Jul 2014
AbstractforBortezomib-based induction therapy followed by intravenous busulfan–melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma | Full Text | References | PDF (177.1 KB) | Supplemental
  • 398 Views
  • 7 CrossRef citations
  • 0Altmetric
MYD88 mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart
Nikhil Patkar, P. G. Subramanian, Prashant Deshpande, Kiran Ghodke, Prashant Tembhare, Russel Mascarenhas, Aditi Muranjan, Shruti Chaudhary, Bhausaheb Bagal, Sumeet Gujral, Manju Sengar & Hari Menon
Pages: 420-425
Published online: 04 Aug 2014
AbstractforMYD88 mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart | Full Text | References | PDF (329.7 KB) | Supplemental
  • 507 Views
  • 13 CrossRef citations
  • 0Altmetric
Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities
Mohamed E. Salama, Shouying Du, Olga Efimova, Nahla M. Heikal, Erik Wendlandt, Reha M. Toydemir, Sarah South, Sherrie L. Perkins, Jerry W. Hussong & Fenghuang Zhan
Pages: 426-433
Published online: 04 Aug 2014
AbstractforNeoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities | Full Text | References | PDF (3.9 MB) | Supplemental
  • 271 Views
  • 3 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors
Sarah Rausch Osian, Alexis D. Leal, Cristine Allmer, Matthew J. Maurer, Grezegorz Nowakowski, David J. Inwards, William R. Macon, Shawna L. Ehlers, George J. Weiner, Thomas M. Habermann, James R. Cerhan & Carrie A. Thompson
Pages: 434-439
Published online: 27 Jun 2014
AbstractforWidespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors | Full Text | References | PDF (3.6 MB) | Supplemental
  • 314 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
CCR4 + T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16
Marina Tuzova, Jillian Richmond, Deon Wolpowitz, Clara Curiel-Lewandrowski, Keri Chaney, Thomas Kupper & William Cruikshank
Pages: 440-449
Published online: 06 Jun 2014
AbstractforCCR4 + T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16 | Full Text | References | PDF (3.9 MB) | Supplemental
  • 428 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin
Kehinde U. A. Adekola, Sevim Dalva Aydemir, Shuo Ma, Zheng Zhou, Steven T. Rosen & Mala Shanmugam
Pages: 450-459
Published online: 04 Aug 2014
AbstractforInvestigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin | Full Text | References | PDF (2.1 MB) | Supplemental
  • 539 Views
  • 37 CrossRef citations
  • 0Altmetric
Article
MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia
Wenjie Jiang, Jie Min, Xiaohui Sui, Yanyan Qian, Ying Liu, Zhaojian Liu, Haibin Zhou, Xi Li & Yaoqin Gong
Pages: 460-471
Published online: 25 Jun 2014
AbstractforMicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia | Full Text | References | PDF (5.8 MB) | Supplemental
  • 1530 Views
  • 30 CrossRef citations
  • 0Altmetric
Open Access
Article
Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia
Guangsong Su, Xueqi Lian, Dongming Tan, Huiquan Tao, Hong Liu, Suning Chen, Hongchao Yin, Depei Wu & Bin Yin
Pages: 472-479
Published online: 25 Jun 2014
AbstractforAberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia | Full Text | References | PDF (518.5 KB) | Supplemental
  • 182 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset
Stefan Nagel, Stefan Ehrentraut, Corinna Meyer, Maren Kaufmann, Hans G. Drexler & Roderick A. F. MacLeod
Pages: 480-491
Published online: 12 Jun 2014
AbstractforRepressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset | Full Text | References | PDF (8.3 MB) | Supplemental
  • 316 Views
  • 28 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations
Valentina Pennucci, Roberta Zini, Ruggiero Norfo, Paola Guglielmelli, Elisa Bianchi, Simona Salati, Giorgia Sacchi, Zelia Prudente, Elena Tenedini, Samantha Ruberti, Chiara Paoli, Tiziana Fanelli, Carmela Mannarelli, Enrico Tagliafico, Sergio Ferrari, Alessandro M. Vannucchi, Rossella Manfredini & on behalf of Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative (AGIMM) Investigators
Pages: 492-496
Published online: 16 Jun 2014
First Page PreviewforAbnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations | Full Text | References | PDF (5 MB) | Supplemental
  • 721 Views
  • 12 CrossRef citations
  • 0Altmetric
Letter
Ruxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts
Ali Tabarroki, Yogen Saunthararajah, Valeria Visconte, Tracy Cinalli, Kristin Colaluca, Heesun J. Rogers, Mikkael A. Sekeres, Hien K. Duong, Brady L. Stein & Ramon V. Tiu
Pages: 497-499
Published online: 27 May 2014
First Page PreviewforRuxolitinib in combination with DNA methyltransferase inhibitors: clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts | Full Text | References | PDF (105.4 KB) | Supplemental
  • 967 Views
  • 15 CrossRef citations
  • 0Altmetric
Letter
What is the optimal dose of high-dose methotrexate in the initial treatment of primary central nervous system lymphoma?
Samir Dalia, Samantha Price, Peter Forsyth, Lubomir Sokol & Michael Jaglal
Pages: 500-502
Published online: 17 Jul 2014
First Page PreviewforWhat is the optimal dose of high-dose methotrexate in the initial treatment of primary central nervous system lymphoma? | Full Text | References | PDF (94.4 KB) | Supplemental
  • 190 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
High rate of both hematopoietic and solid tumors associated with large granular lymphocyte leukemia
Aaron D. Viny & Jaroslaw P. Maciejewski
Pages: 503-504
Published online: 17 Jul 2014
CitationforHigh rate of both hematopoietic and solid tumors associated with large granular lymphocyte leukemia | Full Text | References | PDF (92.1 KB) | Supplemental
  • 238 Views
  • 13 CrossRef citations
  • 0Altmetric
Letter
Epstein–Barr virus-associated diffuse large B-cell lymphoma arising in atrial myxoma: a proposal for a modified therapeutic approach
Umit Tapan, J. Bruno Pestana, John C. Lee & Adam Lerner
Pages: 505-507
Published online: 27 Jun 2014
First Page PreviewforEpstein–Barr virus-associated diffuse large B-cell lymphoma arising in atrial myxoma: a proposal for a modified therapeutic approach | Full Text | References | PDF (532.5 KB) | Supplemental
  • 162 Views
  • 11 CrossRef citations
  • 0Altmetric
Letter
Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma
Karen Hutchinson, Sudy Jahangiri, Laura M. Calvi, Paul Barr, Jonathan W. Friedberg & Jennifer L. Kelly
Pages: 508-511
Published online: 15 Jul 2014
First Page PreviewforImpact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma | Full Text | References | PDF (434.6 KB) | Supplemental
  • 184 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
A different kind of “allogeneic transplant”: successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma
Jason A. Trubiano, Anupkumar George, Jennifer Barnett, Mahendra Siwan, Alexander Heriot, H. Miles Prince, Monica A. Slavin & Benjamin W. Teh
Pages: 512-514
Published online: 15 Jul 2014
First Page PreviewforA different kind of “allogeneic transplant”: successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma | Full Text | References | PDF (101.5 KB) | Supplemental
  • 289 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
Absolute monocyte count is a prognostic indicator in a patient with diffuse large B-cell lymphoma after autologous peripheral blood stem cell transplant
Hongnan Mo, Yuankai Shi, Xiaohong Han, Peng Liu, Jianliang Yang, Changgong Zhang, Shen Yang, Yan Qin, Lin Gui, Youwu Shi, Jiarui Yao, Liya Zhao & Shuxiang Zhang
Pages: 515-517
Published online: 15 Jul 2014
First Page PreviewforAbsolute monocyte count is a prognostic indicator in a patient with diffuse large B-cell lymphoma after autologous peripheral blood stem cell transplant | Full Text | References | PDF (217.4 KB) | Supplemental
  • 225 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Routine radiographic screening after completion of initial chemotherapy and relapse-free survival after transplant in patients with relapsed lymphoma
Siddhartha Ganguly, Jennifer McRae, Jianghua He, Clint Divine, Sunil Abhyankar, Omar Aljitawi & Joseph P. McGuirk
Pages: 518-519
Published online: 15 Jul 2014
CitationforRoutine radiographic screening after completion of initial chemotherapy and relapse-free survival after transplant in patients with relapsed lymphoma | Full Text | References | PDF (123.4 KB) | Supplemental
  • 52 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Myelodysplastic syndrome with extramedullary erythroid hyperplasia induced by loss of Tet2 in mice
Tomoya Muto, Goro Sashida, Nagisa Hasegawa, Chiaki Nakaseko, Koutaro Yokote, Kazuya Shimoda & Atsushi Iwama
Pages: 520-523
Published online: 17 Jul 2014
First Page PreviewforMyelodysplastic syndrome with extramedullary erythroid hyperplasia induced by loss of Tet2 in mice | Full Text | References | PDF (328.7 KB) | Supplemental
  • 228 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Two cases of myelofibrosis with severe thrombocytopenia and symptomatology successfully treated with combination of pomalidomide and ruxolitinib
Mirela Andrei, Hemant Sindhu & Jen Chin Wang
Pages: 524-526
Published online: 15 Jul 2014
First Page PreviewforTwo cases of myelofibrosis with severe thrombocytopenia and symptomatology successfully treated with combination of pomalidomide and ruxolitinib | Full Text | References | PDF (214.7 KB) | Supplemental
  • 624 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
A novel translocation (6;20)(q13;q12) in acute myeloid leukemia likely results in LMBRD1–CHD6 fusion
Nathalie Douet-Guilbert, Etienne De Braekeleer, Corinne Tous, Nadia Guéganic, Audrey Basinko, Marie-Josée Le Bris, Frédéric Morel & Marc De Braekeleer
Pages: 527-528
Published online: 15 Jul 2014
CitationforA novel translocation (6;20)(q13;q12) in acute myeloid leukemia likely results in LMBRD1–CHD6 fusion | Full Text | References | PDF (206.4 KB) | Supplemental
  • 198 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
High levels of CD160 expression up-regulated counts of chronic lymphocytic leukemia cells and were associated with other clinical parameters in Chinese patients with chronic lymphocytic leukemia
Zheng-Hao Zhang, Shu Chen, Shuang Chen, Yang Liu & Jian-Hua Qu
Pages: 529-532
Published online: 17 Jul 2014
First Page PreviewforHigh levels of CD160 expression up-regulated counts of chronic lymphocytic leukemia cells and were associated with other clinical parameters in Chinese patients with chronic lymphocytic leukemia | Full Text | References | PDF (341.3 KB) | Supplemental
  • 102 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma
Zartash Gul, Qaiser Bashir, Martin Cremer, Syed Wamique Yusuf, Hilal Gunaydin, Shaily Arora, Stacey Slone, Yago Nieto, Nazeer Sherwani, Simrit Parmar, Nina Shah, Yvonne T. Dinh, Chitra M. Hosing, Uday R. Popat, Partow Kebriaei, Elizabeth J. Shpall, Sergio A. Giralt, Richard E. Champlin & Muzaffar H. Qazilbash
Pages: 533-535
Published online: 15 Jul 2014
First Page PreviewforShort-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma | Full Text | References | PDF (100.7 KB) | Supplemental
  • 386 Views
  • 12 CrossRef citations
  • 0Altmetric
Letter
Toxoplasmosis in patients with hematologic malignancies
Ashish Chintakuntlawar, Michael Kidd, Aref Al-Kali, Walter Wilson & Carrie A. Thompson
Pages: 536-538
Published online: 17 Jul 2014
First Page PreviewforToxoplasmosis in patients with hematologic malignancies | Full Text | References | PDF (153.7 KB) | Supplemental
  • 287 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Mediastinal isolated myeloid sarcoma: a single-institution experience
Mariella D'Angiò, Paolo Paesano, Luisa Quattrocchi, Walter Barberi, Teresa Ceglie, Irene Avagnina, Maria Stefania de Propris, Silvia Trisolini & Anna Maria Testi
Pages: 539-541
Published online: 04 Feb 2015
First Page PreviewforMediastinal isolated myeloid sarcoma: a single-institution experience | Full Text | References | PDF (355.4 KB) | Supplemental
  • 146 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Shelf-life extension of azacitidine: waste and cost reduction in the treatment of myelodysplastic syndromes
Hany R. Guirguis, Lauren F. Charbonneau, Ivan Tyono, Richard A. Wells, Matthew C. Cheung & Rena Buckstein
Pages: 542-544
Published online: 17 Jul 2014
First Page PreviewforShelf-life extension of azacitidine: waste and cost reduction in the treatment of myelodysplastic syndromes | Full Text | References | PDF (357.8 KB) | Supplemental
  • 425 Views
  • 2 CrossRef citations
  • 0Altmetric

Correspondence

XRCC3 Thr241Met (rs861539) polymorphism and leukemia risk: unresolved controversy
Su-yi Li & Mo Yang
Page: 545
Published online: 25 Jun 2014
CitationforXRCC3 Thr241Met (rs861539) polymorphism and leukemia risk: unresolved controversy | Full Text | References | PDF (79.7 KB) | Supplemental
  • 72 Views
  • 0 CrossRef citations
  • 0Altmetric
BCR–ABL1 T315I mutation, a negative prognostic factor for the terminal phase of chronic myelogenous leukemia treated with first- and second-line tyrosine kinase inhibitors, might be an indicator of allogeneic stem cell transplant as the treatment of choice
Ciprian Tomuleasa, Delia Dima, Ioana Frinc, Mariana Patiu, Bobe Petrushev, Andrei Cucuianu & Ioana Berindan-Neagoe
Pages: 546-547
Published online: 19 Aug 2014
CitationforBCR–ABL1 T315I mutation, a negative prognostic factor for the terminal phase of chronic myelogenous leukemia treated with first- and second-line tyrosine kinase inhibitors, might be an indicator of allogeneic stem cell transplant as the treatment of choice | Full Text | References | PDF (250.2 KB) | Supplemental
  • 126 Views
  • 6 CrossRef citations
  • 0Altmetric
Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma
Barbara Kiesewetter & Markus Raderer
Pages: 548-549
Published online: 07 Oct 2014
CitationforUnderlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma | Full Text | References | PDF (84.5 KB) | Supplemental
  • 312 Views
  • 0 CrossRef citations
  • 0Altmetric
Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma: author's reply
Vittorio Montefusco
Page: 550
Published online: 08 Sep 2014
CitationforUnderlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma: author's reply | Full Text | References | PDF (78.9 KB) | Supplemental
  • 270 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Direct and indirect costs for patients with myeloproliferative neoplasms
Jingbo Yu et al.
Article | Published online: 27 Apr 2024
Open Access
Targets and treatments in primary CNS lymphoma
Christina von Roemeling et al.
Review Article | Published online: 24 Apr 2024
Open Access
Challenges in management of older patients with chronic myeloid leukemia
Jessica M. Stempel et al.
Review Article | Published online: 23 Apr 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr et al.
Article | Published online: 23 Apr 2024
Open Access
View all latest articles